Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cosmo Pharmaceuticals NV
LSE:0RGI
Cosmo Pharmaceuticals NV
LSE:0RGI
Price:
52.1
CHF
-1.33%
Market Closed
Market Cap:
CHf781.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cosmo Pharmaceuticals NV
LSE:0RGI
|
IE |
|
IDEAYA Biosciences Inc
F:30J
|
US |
|
B
|
Bank Multiarta Sentosa Tbk PT
IDX:MASB
|
ID |
|
C
|
Churchill Downs Inc
SWB:CHR
|
US |
|
V
|
Vale Indonesia Tbk PT
SWB:XT3B
|
ID |
|
Recticel SA
F:RCZ
|
BE |
|
Trigano SA
PAR:TRI
|
FR |
|
A
|
Austral Gold Ltd
XTSX:AGLD
|
AU |
|
E
|
East West Bancorp Inc
F:EW2
|
US |
|
S
|
SFA Semicon Co Ltd
KOSDAQ:036540
|
KR |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
F:MOGG
|
HU |
|
R
|
RomReal Ltd
OSE:ROM
|
BM |
|
V
|
Vale Indonesia Tbk PT
F:XT3B
|
ID |
|
P
|
PeopleBio Inc
KOSDAQ:304840
|
KR |
|
Grid Battery Metals Inc
XTSX:CELL
|
CA |
|
E
|
Euronext Athens Holding SA
XMUN:HEE
|
GR |
|
I
|
Imperial Metals Corp
F:L7D
|
CA |
|
S
|
Shakarganj Ltd
KAR:SML
|
PK |
|
P
|
Pivotree Inc
OTC:PVTRF
|
CA |
|
Babylon Pump & Power Ltd
ASX:BPP
|
AU |
|
N
|
Noontalk Media Ltd
SGX:SEJ
|
SG |
|
J
|
Julius Baer Gruppe AG
OTC:JBAXY
|
CH |
|
B
|
Burshane LPG (Pakistan) Ltd
KAR:BPL
|
PK |
|
Tessenderlo Group NV
OTC:TSDOF
|
BE |
Wall St Price Targets
0RGI Price Forecast
Based on 7 analysts
Based on 7 analysts
+125% Upside
from
CHf52.1
today
Cosmo Pharmaceuticals NV (0RGI)’s 12-month stock price forecast through October 2027 has a consensus target of CHf117.3, implying 125% upside. The forecast is based on price targets from 7 Wall Street analysts.
0RGI Analyst Rating
No ratings yet
No ratings yet
Cosmo Pharmaceuticals NV Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0RGI's stock price target?
Price Target
117.3
CHF
117.3
CHF
According to Wall Street analysts, the average 1-year price target for 0RGI is 117.3 CHF with a low forecast of 80.8 CHF and a high forecast of 168 CHF.
What is the Revenue forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
38%
38%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 38%.
What is the Gross Profit forecast for Cosmo Pharmaceuticals NV?
Projected CAGR
44%
44%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 8 years is 44%.